Citigroup »

Karyopharm Therapeutics shares owned by Citigroup

Quarter-by-quarter ownership of Karyopharm Therapeutics (KPTI) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Karyopharm Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Karyopharm Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Karyopharm Therapeutics by Citigroup

Quarter filed Position value Share count Share price at filing
2026-03-31 $28k 4.9k 5.57
2025-03-31 $26k 7.0k 3.75

More positions owned by Citigroup

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Tr Russell 2000 Etf (IWM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Spdr Gold Tr Gold Shs (GLD)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Alphabet Cap Stk Cl C (GOOG)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Bank of America Corporation (BAC)

View all positions for Citigroup

Top funds holding Karyopharm Therapeutics

Ikarian Capital
Commodore Capital
RA Capital Management
T. Rowe Price Investment Management
Goldman Sachs Group
Catalio Capital Management
Affinity Asset Advisors
Susquehanna International
Boothbay Fund Management
Squadron Capital Management
Vanguard Capital Management
Jane Street
Vanguard Group
Millennium Management
Citadel Advisors

View all funds holding Karyopharm Therapeutics